• Date: March 05, 2018
  • Place:
  • Hotel Crowne Plaza
  • Avinguda de Rius i Taulet, 1-3
  • Barcelona
  • show map

Barcelona will be the host city for the 11th Annual Conference of Biomedical Research Technology Platforms, which will be held on 5 and 6 March at the Hotel Crowne Plaza. The event will address the possibilities opened up by the latest genomic technologies in terms of advancing biomedical research and developing new treatments, as well as the importance of digitisation and data analysis in personalised medicine.

The conference programme includes four plenary sessions, one for each of the technology platforms: Innovative Medicines, Nanomedicine, Health Technology and Biotechnology Markets. The conference also offers several parallel sessions, including one covering the practical aspects of data sharing in biomedical research, and another addressing the new paradigms in clinical research, among others. The “la Caixa” Banking Foundation participates on 6 March in the session National and international financing for cooperation in the health sector.

The conference is run by the Spanish Technological Platform for Innovative Medicines (Farmaindustria), together with the Spanish Federation of Healthcare Technology Companies (FENIN), the Spanish Association of Biotech Companies (ASEBIO) and the Spanish Nanomedicine Platform (Nanomed Spain).

  • Registration form

Hotel Crowne Plaza, Barcelona

More events

February 14, 2019

Porto hosts companion diagnostics and biobanking events

On 14 and 15 February, the BioTech Pharma Summit Conference Series will present two events in Porto: 2nd Annual Companion Diagnostics & Biomarkers 2019, and Biobanking 2019.

February 05, 2019

Wearable Technologies event to be held in Munich

On 5 and 6 February, Munich will be hosting the European edition of the Wearable Technologies conference series.

February 05, 2019

London to host partnering event in the life sciences

The 5th annual LSX World Congress will be held on 5 and 6 February in London. The event will bring together key players and leaders in Biotech, Medtech and Healthtech.